Instrument Inactif

Autres langues Yumanity Therapeutics

Actions

YMTX

US98872L1026

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Yumanity Therapeutics : Dosed First Patient in Phase 1/2 Clinical Study of VISTA-Targeting KVA12123 in Advanced Solid Tumors Initial KVA12123 Clinical Data Readout Anticipated by End of 2023 Closed $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules - Form 8-K	11/05/23
Yumanity Therapeutics : Regulation FD Presentation - Form 8-K	17/04/23
Yumanity Therapeutics : VISTA blocking immunotherapy engineered to address immunosuppression in the tumor microenvironment (TME) Phase 1 initial data readout anticipated by end of 2023 - Form 8-K	12/04/23
Yumanity Therapeutics : January 2023 Developing next-generation immunotherapies that address cancer immune resistance KA (Nasdaq) - Form 8-K	05/01/23
Yumanity Therapeutics : Kineta Completes Reverse Merger with Yumanity Therapeutics - Form 8-K	22/12/22
Kineta's Shares Gain Momentum on Nasdaq Debut Following Yumanity Therapeutics Reverse Merger Completion	19/12/22
Kineta, Yumanity Therapeutics Complete Reverse Merger	19/12/22
YUMANITY THERAPEUTICS, INC. Other Events (form 8-K/A)	16/12/22
Yumanity Therapeutics Inc.(NasdaqCM:KA) dropped from NASDAQ Composite Index	16/12/22
Kineta, Inc. completed the acquisition of Yumanity Therapeutics, Inc. from a group of shareholders in a reverse merger transaction.	16/12/22
Yumanity Therapeutics : Acquisition/Asset Disposal - Form 8-K	15/12/22
YUMANITY THERAPEUTICS, INC. : Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits (form 8-K)	15/12/22
Sector Update: Health Care Stocks Stage Small Recovery Late	14/12/22
Sector Update: Health Care	14/12/22
Top Midday Decliners	14/12/22
Stocks Remain Relatively Flat as Investors Wait for Fed Rate-Hike Move	14/12/22
Investors Remain Sidelined in Premarket Trading Ahead of Fed Decision Wednesday	14/12/22
Top Premarket Decliners	14/12/22
YUMANITY THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	13/12/22
YUMANITY THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	06/12/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Yumanity Therapeutics

Actions

YMTX

US98872L1026

Autres langues

Filtres